The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention ...
The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
The Ghana AIDS Commission (GAC) says the lack of funding can impact negatively efforts to end AIDS as a public health threat ...
GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...
The Executive Director of UNAIDS Winnie Byanyima is calling for accelerated global solidarity to strengthen Madagascar's response to HIV, including preventing new HIV infections and expanding access ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback